Home » Topics » Regulatory

Regulatory
RSS

Minocycline associated with marked long-term efficacy in early RA

Nov. 13, 1997

Dura submits NDA for Albuterol Spiros

Nov. 12, 1997

FDA approves Intron A for non-Hodgkin's lymphoma

Nov. 12, 1997

P&U's Genotropin approved by FDA for adult growth hormone deficiency

Nov. 12, 1997

FDA clears Fortovase

Nov. 10, 1997

ReoPro cleared in U.S. for expanded labeling

Nov. 7, 1997

Apomorphine designated orphan drug

Nov. 7, 1997

Gensia Sicor terminates collaboration with Atrix

Nov. 7, 1997

Patient enrollment complete for phase II trial of memantine

Nov. 6, 1997

FDA approves generic formulation of oxycodone/acetaminophen

Nov. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...